Continuous positive airway pressure delivery interfaces for obstructive sleep apnoea

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2006, Pages

  Chai, Ching Li ^a   Pathinathan, A ^b   Smith, B ^b  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AIRWAY PRESSURE; AROUSAL; CINAHL; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DATA ANALYSIS; DATA COLLECTION METHOD; DATA EXTRACTION; EMBASE; EPWORTH SLEEPINESS SCALE; HUMAN; MASK; MEDLINE; OXYGEN SATURATION; PATIENT COMPLIANCE; PATIENT SATISFACTION; POSITIVE END EXPIRATORY PRESSURE; QUALITY OF LIFE; REVIEW; SLEEP APNEA SYNDROME; STATISTICAL ANALYSIS; SYMPTOM; THERAPY EFFECT;

EID: 42749103821     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD005308.pub2     Document Type: Review

References (25)

1. Anderson FE, Kingshott RN, Taylor DR, Jones DR, Kline LR, Whyte KF. A randomized crossover efficacy trial of oral CPAP (Oracle) compared with nasal CPAP in the management of obstructive sleep apnea. Sleep 2003;26(6):721-6.
2. Khanna R, Kline LR. A prospective 8 week trial of nasal interfaces vs. a novel oral interface (Oracle) for treatment of obstructive sleep apnea hypopnea syndrome. Sleep Medicine 2003;4:333-8.
3. Massie CA, Hart RW. Clinical outcomes related to interface type in patients with obstructive sleep apnea/hypopnea syndrome who are using continuous positive airway pressure. Chest 2003;123:1112-8.
4. Mortimore IL, Douglas NJ. Comparison of nose and face mask CPAP therapy for sleep apnoea. Thorax 1998;53:290-2.
5. Beecroft J, Zanon S, Lukic D, Hanly P. Oral continuous positive airway pressure for sleep apnea - effectiveness, patient preference and adherence. Chest 2003;124:2200-8.
6. Forman M, Rankin N, Whyte K, Jordan V. Use of face mask instead of nasal mask to overcome drying of the airways during CPAP. American Journal of Respiratory & Critical Care Medicine 2002;165(Suppl 8):A410.
7. Prosise GL, Berry RB. Oral-nasal continuous positive airway pressure as a treatment for obstructive sleep apnea. Chest 1994;106:180-6.
8. Sanders MH, Kern NB, Stiller RA, Strollo PJ, Martin TJ, Atwood CW. CPAP therapy via oronasal mask for obstructive sleep apnea. Chest 1994;106:774-9.
9. Smith PL, O'Donnell CP, Allan L, Schwartz AR. A physiologic comparison of nasal and oral positive airway pressure. Chest 2003;123:689-94.
10. Wilson GN, Piper AJ, Norman M, Chaseling WG, Millross MA, Collins ER, et al. Nasal versus full face mask for noninvasive ventilation in chronic respiratory failure. European Respiratory Journal 2004;23(4):605- 9.
11. Barbe F, Pericas J, Munoz A, Findley L, Anto JM, Agusti AGN. Automobile accidents in patients with sleep apnea syndrome. American Journal of Respiratory & Critical Care Medicine 1998;158:18-22.
12. Cates C. Visual Rx. Online NNT Calculator. http://www.nntonline.net. Cates C, 2003.
13. Engleman HM, Martin SE, Kingshott RN, Mackay TW, Deary IJ, Douglas NJ. Randomised placebo controlled trial of daytime function after continuous positive airway pressure (CPAP) therapy for the sleep apnoea/hypopnoea syndrome. Thorax 1998;53:341-5.
14. Engleman HM, Kingshott RN, Wraith PK, Mackay TW, Deary IJ, Douglas NJ. Randomized, placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hyponea syndrome. American Journal of Respiratory & Critical Care Medicine 1999;159:461-7.
15. Giles TL, Lasserson TJ, Smith BJ, White J, Wright J, Cates CJ. Continuous positive airways pressure for obstructive sleep apnoea in adults (Cochrane review). In: The Cochrane Database of Systematic Reviews, 1, 2006.
16. Hannifa M, Lasserson T, Smith I. Interventions to improve compliance with continuous positive airway pressure for obstructive sleep apnoea (Cochrane review). In: The Cochrane Database of Systematic Reviews, 1, 2004.
17. Janson C, Noges E, Svedberg-Randt S, Linberg E. What characterizes patients who are unable to tolerate continuous positive airway pressure (CPAP) treatment?. Respiratory Medicine 2000;94(2):145-9.
18. Jenkinson C, Davies RJO, Mullins R, Stradling JR. Comparison of therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised prospective parallel trial. Lancet 1999;353:2100-5.
19. Kribbs NB, Pack AI, Kline LR, Smith PL, Schwartz AR, Schubert NM, et al. Objective measurement of patterns of nasal CPAP use by patients with obstructive sleep apnea. American Review of Respiratory Disease 1993;147:887- 95.
20. Pepin JL, Leger P, Veale D, Langevin B, Robert D, Levy P. Side effects of nasal continuous positive airway pressure in sleep apnea syndrome. Study of 193 patients in two French sleep centers. Chest 1995;107:375-81.
21. Pepin JL, Krieger J, Rodenstien D, Cornette A, Sforza E, Delguste P, et al. Effective compliance during the first 3 months of continuous positive airways pressure. American Journal of Respiratory and Critical Care Medicine 1999;160:1124-9.
22. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. The New England Journal of Medicine 2000;342:1378-84.
23. Popescu G, Latham M, Allgar V, Elliot MW. Continuous positive airway pressure for sleep apnoea/hypopnoea syndrome: usefulness of a 2 week trial to identify factors associated with long termuse. Thorax 2001;56:727-33.
24. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto FJ, et al. Sleep disordered breathing and cardiovascular disease. American Journal of Respiratory and Critical Care Medicine 2001;163:19-25.
25. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. The New England Journal of Medicine 1993;328:1230-5.